Projects funded by the NCN

The new homology model of H3 histaminic receptor - structure, interaction with ligand

Call: PRELUDIUM 8 , Panel: NZ7

Principal investigator: Jakub Józef Jończyk

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Development of cellular models for the investigation of histamine H3 and H4 receptors pharmacology.

Call: PRELUDIUM 1 , Panel: NZ4

Principal investigator: Tadeusz Piotr Karcz

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

The impact of H3 histamine receptor modulation on oligodendrogenesis and neurogenesis: a new strategy for the treatment ...

Call: PRELUDIUM 24 , Panel: NZ5

Principal investigator: Maciej Degutis

Instytut Farmakologii PAN

NMR Spectroscopy as Molecular Language: A Deep Learning Approach to Bioactivity Prediction

Call: PRELUDIUM 24 , Panel: NZ7

Principal investigator: Arkadiusz Bogumił Leniak

Instytut Farmakologii PAN

The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

Call: OPUS 23 , Panel: NZ7

Principal investigator: dr Katarzyna Anna Szczepańska

Instytut Farmakologii PAN

Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system...

Call: SONATINA 4 , Panel: NZ7

Principal investigator: Katarzyna Anna Szczepańska

Instytut Farmakologii PAN

Histamine H3/H4 receptors as the attractive target for the search of biologically active substances

Call: MAESTRO 1 , Panel: NZ4

Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

Call: SONATA 15 , Panel: NZ7

Principal investigator: dr Katarzyna Popiołek-Barczyk

Instytut Farmakologii PAN

Analysis and evaluation of the effectiveness of anorexic and safety properties for the new histamine H3 receptor ligands

Call: OPUS 12 , Panel: NZ7

Principal investigator: dr hab. Magdalena Bogumiła Kotańska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

New perspective in Alzheimer's disease therapy - multifunctional histamine H3 receptor ligands?

Call: OPUS 12 , Panel: NZ7

Principal investigator: dr hab. Dorota Łażewska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Piperazine derivatives as active histamine H3 receptor ligands - molecular modeling, synthesis, pharmacological evaluati...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Katarzyna Anna Szczepańska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny